A(AR3) were produced by the microbial conversion of saframycin A(SA). Efficient conversion of SA to AR, and AR3 was observed with Rhodococcus amidophifus IFM 144. Though the antimicrobial activity of AR, was one tenth that of SA, the in vitro antitumor activity of AR1 was found to be equivalent to that of SA. In contrast, AR, was biologically less active.
For antitumor antibiotics, considerable attention has been given to the microbial reduction of carbonyl groups in relation to antitumor activities . [4] [5] [6] [7] [8] The antitumor activity of a novel antibiotic, saframycin A, with a unique structure consisting of a dimer of 6-methyl-7-methoxy-1,2,3,4-tetrahydroisoquinoline-5,8-dione, as the basic skeleton, has been reported . [9] [10] [11] [12] In our studies on the microbial conversion of SA into antibiotics possessing antitumor spectra different from those of the parent compound (SA), reduction of the side chain carbonyl group of SA was observed.
In this paper, we report our studies on the microbial conversion of SA to AR, and AR, and their biological properties.
Materials and Methods
Microorganisms and Cultivation Rhodococcus amidophih{s IFM 144 was maintained on slants of I % glycerol nutrient medium until used. The strain was grown in 500-ml Erlenmeyer flasks, each containing 100 ml of a medium consisting of: meat extract 1 %, peptone 1 %, yeast extract 1 %, NaCl 0.3 % (pH 7.2). After 48 hours incubation at 27°C on a rotary shaker at 250 rpm, the culture was centrifuged, washed and suspended in a small volume (23 ml) of 0.1 M phosphate buffer (pH 7.5).
Microbial Conversion of Saframyicn A(SA) Two ml of the suspension was mixed with 2 ml of the 10% aqueous methanol solution of SA (0.5 mg/ ml) in a test tube and the mixture incubated at 37°C for 18 hours. The reaction mixture was centrifuged at 500 rpm, and the supernatant extracted with ethyl acetate. The ethyl acetate layer was concentrated in vacuo, and the residue extracted with 1 N HCl solution. After adjustment to pH 7.5 with conc. NH,OH, the extract was re-extracted with ethyl acetate and the solvent layer concentrated to dryness. The residue was further purified by silica gel TLC (GFC254, Merck) using chloroform -acetone (1: 1, v/v) as solvent. The bioconversion products on TLC plates were monitored using a dual wave-length chromatogram scanner (Shimadzu CS-910) at 270 nm.
Preparative TLC plates developed with the solvent system described above were used to obtain a sample for physicochemical analysis.
Chemical Reduction of Saframycin A (SA) and Saframycin B (SB) One hundred mg of SA or SB was dissolved in 10 ml of 10 % aqueous methanol solution, and to the solution was slowly added 10 mg of NaBH4. After stirring at room temperature for 10 minutes, the reaction mixture was extracted with ethyl acetate. The solvent layer was washed with distilled water and concentrated in vacuo. The residue was further purified by preparative TLC using ethyl acetatebenzene (2: 1, v/v) as a solvent system. Antimicr _obialActivity of AR1 and-AR3. Twenty two bacteria and eight fungi maintained in our laboratory were used in this experiment. Minimum inhibitory concentration (MIC) was determined by the agar streak method using 0.5% nutrient agar for bacteria and Sabouraud dextrose agar for fungi. The results were observed after incubation at 37°C for 48 to 72 hours.
In vitro Cytotoxicity Determination In vitro antitumor activity was determined using a cultured cell line of L1210 mouse leukemia in suspension as described by ARAI et al.12) ED50 was determined by the method of IsHIwATA.13) Spectroscopic Measurements Melting points were determined on a Yamato melting point apparatus (Model MP-21, Yamato Kagaku, Japan) and are uncorrected. Optical rotations were measured on a DPI-4 polarimeter (Jasco, Japan). Ultraviolet absorption spectra (UV) were determined on a Hitachi 323 spectrophotometer (Hitachi, Japan) and infrared absorption spectra (IR) were taken on an IRA-2 spectrometer (Jasco, Japan). NMR spectra were determined on a JNM-PFT-100 (JEOL, Japan) with tetramethylsilane (TMS) as a internal standard. Mass spectra were determined on a JSM-01SG-2 double focusing mass spectrometer (JEOL, Japan) using field desorption method.
Results and Discussion
As shown in Fig (Fig. 3) . The 13C NMR spectrum of AR3 is shown in Table 2 .
The fact that the UV and IR spectra of AR, and AR3 were very similar to those of SA suggested that Consequently, the presence of a -CH(OH)-CH3 group in AR1 and AR3 clearly indicated that the C-25 ketone of the pyruvoylamine group of SA was reduced to a carbinol17). Furthermore, in the spectra of (t, CH3) was observed. These spectral data indicated that AR3 should have the same carbon skeleton as saframycin B (SB). Moreover, the molecular formulas and mass spectra of AR1 and AR3 supported the structure containing one more hydroxyl group than SA and SB, respectively. 10.11) Therefore, the structures of AR1 and AR3 were determined as 25-dihydrosaframycin A and 21-decyano-25-dihydrosaframycin A (25-dihydrosaframycin B), respectively (Fig. 4) .
The chemical reduction of SA with NaBH4 gave two products, saframycin AH1(AH1) and saframycin AH2(AH2) in a 1: 1 ratio. NMR spectra of AH, and AH, are shown in Table 2 . These physicochemical data of AH1 and AH2
indicated that these two compounds are stereoisorners at C-25; furthermore AH2 was identified as AR1 by TLC, mass, 1H NMR, 13C NMR and IR spectra.
On the other hand, the chemical reduction of SB with NaBH4 under the conditions described above gave two products, saframycin BH1(BH1) and saframycin BH2(BH2) in a 10: 1 ratio. (Table 2) showed that the reduction occurred at the same site as that observed in the conversion of SA into AH1 and AH2. BH, could not be purified further due to the lack of sufficient material. Moreover, BH1 was found identical with AR3 by comparison of TLC, 1H NMR, 11C NMR and IR spectra. These results further confirmed the structure of AR3 as 25-dihydrosaframycin B(21-decyano-25-dihydrosaframycin A). BH2 is assumed to be a stereoisomer of BH1. The absolute configuration of the newly formed asymmetric carbon at the C-25 site remains to be determined.
As shown in Table 3 , AR, showed higher activity against Gram-positive bacteria than against Gramnegative bacteria, and no activity against fungi. Corynebacterium diphtheriae was most sensitive to AR1, and completely inhibited by 0.01 iig/ml. Compared to the parent compound (SA), AR, was 5 to 10 times less active against microorganisms. AR3 proved to be 10 to 50 times less active than AR1.
The ED50 of SA, AR1 and AR3 against L1210 mouse leukemia cell line was 0.003 tog/ml, 0.004 t?g/ ml, and 0.35 iag/ml, respectively. In our preliminary study of AR1 and AR3 against L1210 mouse leuke- Therefore, the reduction of the carbonyl group in the side chain of SA resulted in a marked loss of antimicrobial activity, and a negligible loss of antitumor activity. Reduction of the C-21 carbon on the basic skeleton of SA, at the attachment site of the cyano group, which leads to the release of cyanide, resulted in almost complete loss of biological activity. This also confirms the importance of the cyano group for the manifestation of the biological activity of SA, as described previously.18)
